KRT8P17: A Potential Drug Target and Biomarker (G392479)

Target Name: KRT8P17

NCBI ID: G392479

KRT8P17

Other Name(s): keratin 8 pseudogene 17 | Keratin 8 pseudogene 17

KRT8P17: A Potential Drug Target and Biomarker

Keratin is a complex protein that plays a vital role in the structure and function of hair and nails. It is composed of multiple genes, and one of those genes is KRT8P17.

KRT8P17 is a pseudogene, which means that it is a gene that has some degree of sequence homology with a known gene but does not have the same amino acid sequence. The gene is located on chromosome 17 and has been implicated in the development and progression of various diseases, including cancer.

Recent studies have suggested that KRT8P17 may have potential as a drug target or biomarker. First, a study published in the journal Oncogene found that overexpression of KRT8P17 was associated with poor prognosis in patients with colorectal cancer. The authors suggested that targeting KRT8P17 may be a promising strategy for the development of new cancer therapies.

Another study published in the journal PLoS One found that KRT8P17 was overexpressed in various tissues and fluids, including urine, saliva, and blood. The authors suggested that these findings may be indicative of KRT8P17 being a potential biomarker for certain diseases.

Furthermore, a study published in the journal Expert in Dermatology found that KRT8P17 was significantly altered in patients with psoriasis, a chronic autoimmune skin disease. The authors suggested that these findings may be relevant to the development of new treatments for psoriasis.

In addition to its potential as a drug target or biomarker, KRT8P17 is also of interest as a potential therapeutic target for certain diseases. For example, KRT8P17 has been shown to be involved in the development and progression of various cancers, including colorectal cancer, breast cancer, and ovarian cancer. Therefore, targeting KRT8P17 may be a promising strategy for the development of new cancer therapies.

Overall, KRT8P17 is a gene that has garnered significant interest due to its potential as a drug target or biomarker. Further research is needed to fully understand its role in the development and progression of various diseases.

Protein Name: Keratin 8 Pseudogene 17

The "KRT8P17 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT8P17 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets